ETF Series Solutions Trust Range Cancer Therapeutics ETF

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch CNCR and buy or sell other stocks, ETFs, and their options commission-free!

About CNCR

CNCR tracks an equal-weighted index of companies currently developing oncology drugs or selling cancer therapeutic products. 

CNCR Key Statistics

AUM
—
AUM—
Price-Earnings ratio
—
Price-Earnings ratio—
30-Day yield
—
30-Day yield—
Average volume
—
Average volume—
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$13.28
52 Week high$13.28
52 Week low
$7.88
52 Week low$7.88
Expense ratio
—
Expense ratio—

Stock Snapshot

With a market cap of 7.04M, ETF Series Solutions Trust Range Cancer Therapeutics ETF(CNCR) trades at $9.02. currently yields dividends of 14.1%.

ETF Series Solutions Trust Range Cancer Therapeutics ETF(CNCR) stock opened on 2025-12-12 at —. The price climbed to — and dipped to —.

ETF Series Solutions Trust Range Cancer Therapeutics ETF(CNCR) shares are trading with a volume of 0.

In the last year, ETF Series Solutions Trust Range Cancer Therapeutics ETF(CNCR) shares hit a 52-week high of $13.28 and a 52-week low of $7.88.

In the last year, ETF Series Solutions Trust Range Cancer Therapeutics ETF(CNCR) shares hit a 52-week high of $13.28 and a 52-week low of $7.88.

All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. An investment, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted.